Participants 669 786 5
1397 antiretroviral-treatment-naive patients, presenting at 18 clinical trial units with 80 research sites in the USA
Participants 1479 1533 5
1397 patients were assessed for the composite endpoint
Participants 1546 1637 4
388 participants developed the composite endpoint, 302 developed AIDS or died, and 188 died
Participants 3011 3044 3
treatment-naive patients with HIV
